Canine, human gut microbiomes are similar, researchers say | Monkey study suggests Zika treatment needs modification | Guinea pigs' hearing returns as RNA treatment spurs cochlea hair regrowth
April 25, 2018
FBR Smartbrief
SIGN UP ⋅   FORWARD
Top Story
Canine, human gut microbiomes are similar, researchers say
Canine, human gut microbiomes are similar, researchers say
(Oli Scarff/AFP/Getty Images)
The gut microbiomes in two dog breeds are more similar than mouse or pig microbiomes to the bacterial populations in humans' guts, and changes in dietary carbohydrate and protein levels affected dog and human gut flora similarly. The findings, published in Microbiome, suggest not only that dogs could be good models for human nutrition studies, but also that human nutrition studies might be applicable to dogs.
Popular Science (4/18),  HealthDay News (4/19) 
LinkedIn Twitter Facebook Google+ Email
 
Research Breakthroughs
Monkey study suggests Zika treatment needs modification
An experimental therapy that cleared Zika virus from the blood of pregnant monkeys did not stop the virus from crossing into the amniotic fluid and infecting the fetus, researchers reported in Nature Communications. Researchers will now modify the antibodies so that they can cross the placental barrier and protect the fetus, said lead author Diogo Magnani.
Miami Herald (tiered subscription model) (4/24) 
LinkedIn Twitter Facebook Google+ Email
Guinea pigs' hearing returns as RNA treatment spurs cochlea hair regrowth
RNA-infused nanoparticles delivered to the ears of deafened guinea pigs restored their hearing, according to findings published in Molecular Therapy. Hair cells inside the guinea pigs' ears showed signs of regrowth after being treated with the RNA.
The Scientist online (4/18) 
LinkedIn Twitter Facebook Google+ Email
Hypertension drug slows Parkinson's progression in rodents
Hypertension drug slows Parkinson's progression in rodents
(Damien Meyer/AFP/Getty Images)
Researchers found that acrolein accumulates in rat models of Parkinson's disease and is a key component in disease progression, but the acrolein-scavenging hypertension drug hydralazine alleviated symptoms in the animals. The findings, published in the journal Molecular and Cellular Neuroscience, support the development of acrolein-targeting drugs for Parkinson's disease, said researcher Jean-Christophe Rochet.
Medical News Today (4/22) 
LinkedIn Twitter Facebook Google+ Email
 
Compound temporarily disrupts sperm motility in rhesus macaques
An experimental compound that binds to a protein found on the surface of sperm disrupts their motility, conferring lasting but reversible contraception when injected into male rhesus macaques, researchers reported in PLOS ONE. The researchers are developing an oral form of the compound.
New Atlas (4/22) 
LinkedIn Twitter Facebook Google+ Email
Other News
Animal Health
Larger trial planned for canine osteosarcoma immunotherapy
Researchers at 11 university-based veterinary centers will compare an experimental immunotherapy for osteosarcoma against standard treatment in 80 dogs. The immunotherapy, which combines a molecule that cancer cells express with a modified live form of Listeria monocytogenes, extended survival in an 18-dog pilot study after primary tumor removal and four doses of carboplatin chemotherapy.
American Veterinarian (4/18) 
LinkedIn Twitter Facebook Google+ Email
Prion disease found in camels in Algeria
Prion disease found in camels in Algeria
(Alfredo Estrella/AFP/Getty Images)
An international team of veterinarians and food safety scientists reported in Emerging Infectious Diseases that three dromedary camels in Algeria tested positive for a prion similar to the one that causes bovine spongiform encephalopathy, and they say immediate action should be taken to safeguard animal and human health. The prion could have come from infected feed, and researchers do not know whether it can be passed from animals to people who consume infected meat.
The Telegraph (London) (tiered subscription model) (4/19) 
LinkedIn Twitter Facebook Google+ Email
 
Other News
Policy News
Circuit court says Copyright Act does not allow monkey ownership of selfies
The US Court of Appeals for the 9th Circuit affirmed a lower court's ruling that a crested macaque has no legal right to photographs the monkey snapped of himself with photographer David John Slater's camera. The People for the Ethical Treatment of Animals had sued Slater and self-publishing company Blurb on the monkey's behalf, claiming that publishing and selling the photographs infringed on the monkey's rights under the Copyright Act.
CNN (4/24),  The Washington Post (tiered subscription model) (4/24),  Fox News (4/24) 
LinkedIn Twitter Facebook Google+ Email
FBR News
Donate to FBR
For 35 years, FBR has advanced biomedical research for the sake of both human and animal health. We can't do our job without your support. Please give what you can. Together we will continue to make a difference.
LinkedIn Twitter Facebook Google+ Email
 
  
  
I place a profound belief -- indeed a fervent faith -- in the virtues of self-reliance and personal independence.
Margaret Thatcher,
prime minister
LinkedIn Twitter Facebook Google+ Email
  
  
Learn more about FBR:
About FBR | Donate
About FBR
The Foundation for Biomedical Research (FBR) is the nation’s oldest and largest non-profit dedicated to improving human and animal health by promoting public understanding and support for biomedical research. Our mission is to educate people about the essential role animal research plays in the quest for medical advancements, treatments and cures for both people and animals.
Sign Up
SmartBrief offers 200+ newsletters
Subscriber Tools:
Contact Us:
Editor  -  Melissa Turner
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2018 SmartBrief, Inc.®
Privacy policy |  Legal Information